• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Another family tries to get the word out about monoclonal antibody treatment

Emily

Editor, Senior Moderator
Seems that turf wars have suppressed a treatment that could have save lives.

https://www.timesofisrael.com/wonde...l-antibodies-cured-my-grandparents-from-covid
Wonder drug that works? Monoclonal antibodies ‘cured’ my grandparents from COVID

US government health bodies warn there’s not nearly enough data to prove efficacy, but doctors report no deaths among thousands of high-risk patients prescribed the new treatment

By Julie Masis 28 January 2021, 5:52 pm

...
Now that doctors have been treating patients with monoclonal antibody infusions for about two months, some have stronger evidence that these medications not only prevent deaths but decrease hospitalization rates.

Among Razonable’s 2,000 patients at the Mayo Clinic, only 3% of infusion recipients had to be hospitalized, which is nearly five times lower than the Centers for Disease Control’s estimated 13.8% hospitalization rate for elderly COVID patients.

“It does work as long as it’s given early,” says Razonable.

The hospitalization rate among Huang’s elderly patients in Texas is about 4% — again, significantly lower than average for elderly people with COVID.

Dr. Howard Huang. (Courtesy)



Patients who did need to be hospitalized spent only four days in the hospital on average — “relatively short compared to a lot of COVID cases,” says Huang.

“When you see that the hospitalization rate [in the field] looks similar to the clinical trial, it seems that there is something to what the clinical trial found,” he said.

Still, many hospitals and doctors continue to be reluctant to offer the new treatment....

See also:
Only about a quarter of the doses of monoclonal antibodies that were shipped to hospitals across the country has been used - doctors unaware of this COVID-19 treatment
 
https://www.wpxi.com/news/investigat...BRGX53TL2WO4M/
Monoclonal antibody treatments proving successful at keeping COVID-19 patients out of hospital

March 26, 2021 at 3:48 pm EDTBy Angie Moreschi, WPXI-TVPITTSBURGH ? Libbie Simione is grateful to her son Nathan for finding her a promising COVID-19 treatment in Pittsburgh that helped her to feel better in just days.

?I can never thank him enough for what he?s done from day one, incredible.? Libbie said, choking up.

The 65-year old Carnegie resident was UPMC?S 1000th patient to receive a monoclonal antibody infusion, which is authorized by the FDA for emergency use. She received the treatment one week ago, Friday. Two days later, she started feeling better.

?I was really bad. I was running a high fever, achy all over, coughing and sneezing, shortness of breath? she said. ?I definitely turned the corner by Monday.?

New data encouraging

New data just released BY UPMC shows the mono-clonal antibody treatments are drastically reducing the risk of hospitalization and death in high-risk patients.

?We observed that the monoclonal antibody treatment cut by nearly 70-percent the risk of hospitalization or death,? said UPMC?s Medical Director of Infection Prevention Dr. Graham Snyder, at a news conference announcing the research findings...
...
More information

The treatments are paid for by the federal government, so are free to patients.

It takes about an hour for patients to get the infusions, and then they are monitored for another hour to make sure there is no reaction. UPMC reports the rate of reactions from the treatment is ?extremely low.?

?Only a handful of patients have had any kind of mild reaction, at all. The risk of COVID complications are far higher,? McCreary said.

For more information on UMPC?s monoclonal antibody program, click here or call 1-866-804-5251.
 
Back
Top Bottom